Author

Jeremy Z. R. Han

Garvan Institute of Medical ResearchORCID 0000-0003-1310-6448Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

David R. CroucheriD· 3 shared Antonia L. CadelliD· 2 shared Jing NiiD· 2 shared Jordan F. HastingsiD· 2 shared King Ho LeongiD· 2 shared Misaki S. Clearwater· 2 shared Monica PhimmachanhiD· 2 shared Paul TimpsoniD· 2 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

David R. CroucherORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyScience AdvancesPeer-reviewedNov 28, 2025

Inclusion of JNK-independent drugs within multi-agent chemotherapy improves response in relapsed high-risk neuroblastoma

Jeremy Z. R. Han, Monica Phimmachanh, Jordan F. Hastings…·David R. Croucher

The paper identifies JNK-independent drugs that, when combined with standard chemotherapy, improve response in relapsed high-risk neuroblastoma by exploiting differential apoptotic network utilization.

DOI 10.1126/sciadv.ady5599

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 16, 2025

A selective inhibitor of oncogenic JNK signalling perturbs metastatic outgrowth of triple-negative breast cancer through metabolic blockade

Sharissa L. Latham, Yolande E. I. O’Donnell, Oscar Girgis-Cook…·David R. Croucher

The paper identifies a selective JNK inhibitor that blocks metastasis in triple-negative breast cancer by targeting metabolic pathways.

DOI 10.1101/2025.04.16.649243

humanproteomics

𝕏 PostBluesky

GeneticsScientific ReportsPeer-reviewedNov 5, 2020

A zebrafish functional genomics model to investigate the role of human A20 variants in vivo

Daniele Cultrone, Nathan W. Zammit, Eleanor Self…·Shane T. Grey

This paper uses a zebrafish model to study the in vivo effects of human A20 variants, showing that specific mutations impact A20 function and disease relevance.

12 citations

zebrafishexperimental assay

𝕏 PostBluesky